The preventative role of exogenous melatonin administration to patients with advanced cancer who are at risk of delirium: study protocol for a randomized controlled trial. [electronic resource]
Producer: 20180206Description: 399 p. digitalISSN:- 1745-6215
- Central Nervous System Agents -- administration & dosage
- Clinical Protocols
- Dementia -- diagnosis
- Double-Blind Method
- Feasibility Studies
- Humans
- Melatonin -- administration & dosage
- Neoplasms -- complications
- Ontario
- Palliative Care
- Research Design
- Risk Assessment
- Risk Factors
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.